HIKAL
Back to Income Statement
|
HIKAL Last 5 Year Earnings Per Share (EPS) History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Adjusted EPS | ₹5.64 | ₹6.36 | ₹13.02 | ₹10.80 | ₹6.85 |
What is the latest Earnings Per Share (EPS) of HIKAL ?
| Year | Earnings Per Share (EPS) |
|---|---|
| Mar2025 | ₹5.64 |
| Mar2024 | ₹6.36 |
| Mar2023 | ₹13.02 |
| Mar2022 | ₹10.80 |
| Mar2021 | ₹6.85 |
How is Earnings Per Share (EPS) of HIKAL Trending?
| Years | Earnings Per Share (EPS) | % Change | |
|---|---|---|---|
| Mar2025 | ₹5.64 | -11.32 | |
| Mar2024 | ₹6.36 | -51.15 | |
| Mar2023 | ₹13.02 | 20.56 | |
| Mar2022 | ₹10.80 | 57.66 | |
| Mar2021 | ₹6.85 | - | |
Compare Earnings Per Share (EPS) of peers of HIKAL
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| HIKAL | ₹2,888.3 Cr | -4.3% | 23.3% | -29.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,870.0 Cr | 0.8% | 8.3% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹194,316.0 Cr | 7.1% | 9% | 4.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹169,316.0 Cr | 2% | 12.1% | 49.6% | Stock Analytics | |
| CIPLA | ₹115,477.0 Cr | -0.7% | 4.1% | -3.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,156.0 Cr | -1.7% | -4.2% | -3.1% | Stock Analytics | |
HIKAL Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| HIKAL | -4.3% |
23.3% |
-29.5% |
| SENSEX | 0.6% |
1.2% |
-7.8% |
You may also like the below Video Courses